Found 5 matching trials
Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates
PHASE1This study is an open-label drug-drug interaction (DDI) study of ZYN002 tra...
Location
CMAX Clinical Research
Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)
PHASE2To evaluate the safety and tolerability of ZYN002 administered as a transde...
Location
Greenwood Genetic Center
Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)
PHASE2This trial will evaluate the efficacy and safety of ZYN002, a clear cannabi...
Location
Southwest Autism Research and Resource Center
Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome
PHASE3This is a randomized, double-blind, placebo-controlled, multiple-center stu...
Location
Phoenix Children's Hospital
Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS
PHASE2ZYN002 is a pharmaceutically manufactured Cannabidiol that is developed as ...
Status
Active Not Recruiting
Location
Southwest Autism Research and Resource Center